Global Animal Parasiticides Market Overview

Global Animal Parasiticides Market Size Was Valued at USD 8.53 Billion In 2023 And Is Projected to Reach USD 13.46 Billion By 2032, Growing at A CAGR of 5.2% From 2024 To 2032.

Animal parasiticides refer to substances or mixtures that are used to kill, repel, or control parasites in animals. These parasites can include ticks, fleas, lice, mites, and worms, among others. The global market for animal parasiticides is significant, driven by the increasing awareness about animal health and welfare, the rising prevalence of parasitic infections in livestock and companion animals, and the growing demand for animal-derived products.

The market for animal parasiticides has been growing steadily over the years and is expected to continue expanding. Factors such as increasing pet ownership, growing demand for livestock products, and rising investments in animal healthcare infrastructure contribute to this growth. Ongoing research and development efforts aim to improve the effectiveness, safety, and convenience of animal parasiticides. Innovations in formulations, delivery systems, and active ingredients contribute to product advancements in the market.

Market Dynamics And Factors For The Animal Parasiticides Market

Drivers:

The animal parasiticides market is being driven mainly by the increasing requirements to treat parasitic diseases in animals. Since parasitic attacks are known to support serious economic losses, parasiticides are needed to maintain the health of animals. Factors such as continuous growth in healthcare spending for animal health, rapidly increasing demand for animal-based foods and rise in livestock volumes, continuous increase in pet adoption levels, and the need to defense zoonotic diseases are turning growth in the global animal parasiticides market. Animal meat is a highly nutrient food and so are eggs and milk. With rising disposable incomes, consumers are demanding better quality food products, which is a key growth-promoting factor for the animal parasiticides market. Moreover, the animal welfare activities of governments focused on improving livestock health are also accelerating animal parasiticides market growth. With the number of companion animals on the rise, owners are taking preventive measures to defend the health of pets, thus stimulating growth in the animal parasiticides market.

The market is also being recommended by the steady growth in the numbers of veterinary practitioners, specifically in emerged regions. With the awareness regarding zoonotic diseases rising, governments are stressing efforts to defense transmission of animal diseases to humans, thus boosting demand for animal parasiticides. For instance, ESCAPE, a European body has built up guidelines to prevent, control, and treat companion animal parasites, since dogs and cats are often infested with vector-borne parasites such as ectoparasites and endoparasites. The objective of the European body is to overcome the risk of zoonotic transmission of parasitic diseases by protecting the health of pets. Growth in research activities for emerging innovative parasiticides would also turn the animal parasiticides market growth in the coming years. In addition, for example, Zoetis had remained focused on growing the company`s research for widenings its parasiticide and vaccine product ranges which help to cater the product in the animal parasiticides market.

Restraints:

The application of parasiticide in some animals (specifically the food producers) in some regions is restraining the animal parasiticides market. The growing number of species of parasites are also contributing to the restraints that are preventing the animal parasiticides market from growing. Moreover, the application of parasiticides in livestock animals is subject to various federal regulations in many economies. The extra-label use of these topical parasiticides could leave residues that may, on utilization by human beings, have side effects. As a result, the application of these parasiticides, especially endoparasiticides, needs to be regulated; safe residue concentrations and withdrawal periods for antiparasitics utilized in food-producing animals must be standardized, and slaughtered animals require to be monitored for possible unsafe residues. In the US, animal parasiticides given to food-producing animals have precise FDA-regulated withdrawal times (the time taken post drug administration for drug residues to reach limits set by the FDA) to prevent the presence of harmful drug residues. Similarly, according to the National Organic Program, animal parasiticides are restricted for all organic slaughter stock. In the UK, the Veterinary Medicines Directorate's non-statutory program, in cooperation with the National Surveillance Scheme, carries out residue analysis on imported and processed animal foods to ensure that authorized medicines, including parasiticides, are not present above the permitted level (known as the maximum residue limit) in food. In Canada, the Canadian Food Inspection Agency sets guidelines about withdrawal times for animal drugs, including animal parasiticides.

Opportunities:

Introducing the Door to More Digital Health Solutions

Last year, the start of the COVID-19 pandemic and showing lockdown restrictions led to many veterinarians and pet owners considering telemedicine solutions, owing to the prevention of some in-person appointments. And it's thought this will create the door to more widespread uptake of digital technology in animal care will help the growth of the animal parasiticide market. Already, many pet owners are buying wearable devices for their animals or using apps to monitor daily behavior and determine their four-legged friend on a deeper level. As per the research study, 56 percent of pet owners already own tech just for their pets. Such detailed information could demonstrate invaluable to support veterinary care and the application of artificial intelligence (AI) in practice, which depend on data sets so algorithms can 'learn' regarding a particular disease. Additionally, futuristic technologies are also capturing momentum. For instance, 3D printing is being utilized to build implants, prosthetic limbs, and even tissue replacements for pets. Veterinarians can also utilize 2D images such as scans to produce practice models in preparation for surgery. Vigorous animals are critical for a healthy planet, whether that's in the form of caring for pets, looking after livestock, or defending our wildlife. Continuous research and progress in 2021 and beyond will improve the understanding that can be better care-takers and is expected to grow of the animal parasiticides market in the upcoming years.

Market Segmentation

Segmentation Analysis of Animal Parasiticides Market:

Based on Type, the ectoparasiticides segment is expected to have a maximum animal parasiticides market share of the market, in terms of value during the forecast period. The segment is projected to expand owing to growth in infestation of fleas, ticks, and other ectoparasites to companion animals and livestock, which raises the chances of bacterial, viral, and parasitic disease transmission to humans. Hence, the application of ectoparasiticides is inevitable and important for pets and cattle. These factors are anticipated to turn the segment during the forecast period.

Based on the Animal Type, the companion animal segment is anticipated to record the maximum animal parasiticides market share over the forecast period. The growth of specialized R&D production units by key players in key economies globally and the rising adoption rate of pets as a companion, beast of burden, etc., have led to the major share held by the companion animals' segment of the global animal parasiticides market. Growth in gastrointestinal parasitism and zoonotic diseases among pets is probably to turn the animal parasiticides market over the forecast period.

Based on the End-Users, Veterinary Clinics & Hospitals segment is anticipated to dominate the animal parasiticides market over the forecast period. Largely incorporation of animal parasiticides in hospital settings, the rising incidence of parasitic diseases, and increasing consciousness regarding animal health in developing countries led to the growth of the animal parasiticides market.

Regional Analysis of Animal Parasiticides Market:

The Asia Pacific region holds significant potential as a market for animal parasiticides. The Asia Pacific region is home to a large population of livestock, including cattle, poultry, pigs, and sheep. The growing demand for meat, milk, and other animal-derived products in countries like China, India, and Indonesia drives the need for effective parasite control measures to ensure animal health and productivity. Rapid urbanization and rising disposable incomes in many Asian countries have led to an increase in pet ownership. This trend fuels demand for companion animal parasiticides to protect pets from fleas, ticks, and other parasites, thereby boosting the market for these products.

Governments in the Asia Pacific region are increasingly recognizing the importance of animal health and welfare. They may implement regulations and initiatives to promote the responsible use of parasiticides and ensure the safety and efficacy of these products, thereby fostering market growth. The adoption of advanced technologies and formulations in animal healthcare, including parasiticides, is on the rise in the Asia Pacific region. Innovations such as long-lasting formulations, targeted delivery systems, and novel active ingredients cater to the diverse needs of livestock producers and pet owners in the region.

Players Covered in Animal Parasiticides market are 

•  Bayer AG (Germany)
•  Zoetis Inc. (US)
•  Virbac SA (France)
•  Elanco Animal Health (US)
•  Elanco Animal Health Incorporated (US)
•  Virbac (France)
•  Merck & Co. Inc. (the US)
•  Boehringer Ingelheim GmbH (Germany)
•  Bimeda Animal Health (US)
•  Merck Animal Health (US)
•  Ceva Santé Animale (France)
•  Vetoquinol S.A. (France)
•  PetIQ  Inc. (the US)
•  Norbrook (Ireland) and other major players.

Key Industry Developments In The Animal Parasiticides Market

• In February 2024, Elanco Animal Health sells its aqua business to Merck Animal Health for $1.3 billion in cash, aiming to prioritize investments in larger markets. CEO Jeff Simmons cites the move as strategic, focusing on high-impact innovation and a robust late-stage pipeline, expecting six potential blockbuster products in the U.S. market by 2025. The sale aims to enhance balance sheet flexibility and accelerate deleveraging, targeting net debt to adjusted EBITDA in the high-3x to low-4x range by 2025.
• In October 2023, Bayer Animal Health secure regulatory clearance from the European Union (EU) for its latest offering, NexGard Spectra. This chewable tablet, featuring a combination of afoxolaner and milbemycin oxime, is engineered to address a spectrum of parasites affecting dogs and cats, including fleas, ticks, heartworms, and intestinal worms.
• In November 2023, Elanco Animal Health introduced Seresto Plus, a collar designed for dogs and cats. This innovative product, boasting a formulation of imidacloprid, flumethrin, and pyriproxyfen, offers protection against fleas, ticks, and mosquitoes for a duration of up to eight months. Additionally, it aids in managing flea eggs and larvae within the pet's surroundings.
• In December 2023, with Boehringer Ingelheim's launch of Vectra 3D. This topical solution for dogs contains a blend of dinotefuran, imidacloprid, and permethrin, providing safeguarding against fleas, ticks, and mosquitoes for a month. It also contributes to controlling flea populations in the pet's environment.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Animal Type
 3.3 By End User
 3.4 By Distribution Channels

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Animal Parasiticides Market by Type
 5.1 Animal Parasiticides Market Overview Snapshot and Growth Engine
 5.2 Animal Parasiticides Market Overview
 5.3 Ectoparasiticides
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Ectoparasiticides: Grographic Segmentation
 5.4 Endoparasiticides
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Endoparasiticides: Grographic Segmentation
 5.5 Endectocides
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Endectocides: Grographic Segmentation

Chapter 6: Animal Parasiticides Market by Animal Type
 6.1 Animal Parasiticides Market Overview Snapshot and Growth Engine
 6.2 Animal Parasiticides Market Overview
 6.3 Companion Animals
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Companion Animals: Grographic Segmentation
 6.4 Livestock Animals
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Livestock Animals: Grographic Segmentation

Chapter 7: Animal Parasiticides Market by End User
 7.1 Animal Parasiticides Market Overview Snapshot and Growth Engine
 7.2 Animal Parasiticides Market Overview
 7.3 Animal Farms
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Animal Farms: Grographic Segmentation
 7.4 Home Care Settings
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Home Care Settings: Grographic Segmentation
 7.5 Veterinary Clinics & Hospitals
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Veterinary Clinics & Hospitals: Grographic Segmentation

Chapter 8: Animal Parasiticides Market by Distribution Channels
 8.1 Animal Parasiticides Market Overview Snapshot and Growth Engine
 8.2 Animal Parasiticides Market Overview
 8.3 Veterinary Hospitals & Clinics
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size (2016-2028F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 Veterinary Hospitals & Clinics: Grographic Segmentation
 8.4 Pharmacies
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size (2016-2028F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 Pharmacies: Grographic Segmentation
 8.5 Drug Stores
  8.5.1 Introduction and Market Overview
  8.5.2 Historic and Forecasted Market Size (2016-2028F)
  8.5.3 Key Market Trends, Growth Factors and Opportunities
  8.5.4 Drug Stores: Grographic Segmentation

Chapter 9: Company Profiles and Competitive Analysis
 9.1 Competitive Landscape
  9.1.1 Competitive Positioning
  9.1.2 Animal Parasiticides Sales and Market Share By Players
  9.1.3 Industry BCG Matrix
  9.1.4 Ansoff Matrix
  9.1.5 Animal Parasiticides Industry Concentration Ratio (CR5 and HHI)
  9.1.6 Top 5 Animal Parasiticides Players Market Share
  9.1.7 Mergers and Acquisitions
  9.1.8 Business Strategies By Top Players
 9.2 BAYER AG
  9.2.1 Company Overview
  9.2.2 Key Executives
  9.2.3 Company Snapshot
  9.2.4 Operating Business Segments
  9.2.5 Product Portfolio
  9.2.6 Business Performance
  9.2.7 Key Strategic Moves and Recent Developments
  9.2.8 SWOT Analysis
 9.3 ZOETIS INC.
 9.4 VIRBAC SA
 9.5 ELANCO ANIMAL HEALTH
 9.6 ELANCO ANIMAL HEALTH INCORPORATED
 9.7 VIRBAC
 9.8 MERCK & CO. INC.
 9.9 BOEHRINGER INGELHEIM GMBH
 9.10 BIMEDA ANIMAL HEALTH
 9.11 MERCK ANIMAL HEALTH
 9.12 CEVA SANTÉ ANIMALE
 9.13 VETOQUINOL S.A.
 9.14 PETIQ INC.
 9.15 NORBROOK
 9.16 OTHER MAJOR PLAYERS

Chapter 10: Global Animal Parasiticides Market Analysis, Insights and Forecast, 2016-2028
 10.1 Market Overview
 10.2 Historic and Forecasted Market Size By Type
  10.2.1 Ectoparasiticides
  10.2.2 Endoparasiticides
  10.2.3 Endectocides
 10.3 Historic and Forecasted Market Size By Animal Type
  10.3.1 Companion Animals
  10.3.2 Livestock Animals
 10.4 Historic and Forecasted Market Size By End User
  10.4.1 Animal Farms
  10.4.2 Home Care Settings
  10.4.3 Veterinary Clinics & Hospitals
 10.5 Historic and Forecasted Market Size By Distribution Channels
  10.5.1 Veterinary Hospitals & Clinics
  10.5.2 Pharmacies
  10.5.3 Drug Stores

Chapter 11: North America Animal Parasiticides Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Ectoparasiticides
  11.4.2 Endoparasiticides
  11.4.3 Endectocides
 11.5 Historic and Forecasted Market Size By Animal Type
  11.5.1 Companion Animals
  11.5.2 Livestock Animals
 11.6 Historic and Forecasted Market Size By End User
  11.6.1 Animal Farms
  11.6.2 Home Care Settings
  11.6.3 Veterinary Clinics & Hospitals
 11.7 Historic and Forecasted Market Size By Distribution Channels
  11.7.1 Veterinary Hospitals & Clinics
  11.7.2 Pharmacies
  11.7.3 Drug Stores
 11.8 Historic and Forecast Market Size by Country
  11.8.1 U.S.
  11.8.2 Canada
  11.8.3 Mexico

Chapter 12: Europe Animal Parasiticides Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Ectoparasiticides
  12.4.2 Endoparasiticides
  12.4.3 Endectocides
 12.5 Historic and Forecasted Market Size By Animal Type
  12.5.1 Companion Animals
  12.5.2 Livestock Animals
 12.6 Historic and Forecasted Market Size By End User
  12.6.1 Animal Farms
  12.6.2 Home Care Settings
  12.6.3 Veterinary Clinics & Hospitals
 12.7 Historic and Forecasted Market Size By Distribution Channels
  12.7.1 Veterinary Hospitals & Clinics
  12.7.2 Pharmacies
  12.7.3 Drug Stores
 12.8 Historic and Forecast Market Size by Country
  12.8.1 Germany
  12.8.2 U.K.
  12.8.3 France
  12.8.4 Italy
  12.8.5 Russia
  12.8.6 Spain
  12.8.7 Rest of Europe

Chapter 13: Asia-Pacific Animal Parasiticides Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Ectoparasiticides
  13.4.2 Endoparasiticides
  13.4.3 Endectocides
 13.5 Historic and Forecasted Market Size By Animal Type
  13.5.1 Companion Animals
  13.5.2 Livestock Animals
 13.6 Historic and Forecasted Market Size By End User
  13.6.1 Animal Farms
  13.6.2 Home Care Settings
  13.6.3 Veterinary Clinics & Hospitals
 13.7 Historic and Forecasted Market Size By Distribution Channels
  13.7.1 Veterinary Hospitals & Clinics
  13.7.2 Pharmacies
  13.7.3 Drug Stores
 13.8 Historic and Forecast Market Size by Country
  13.8.1 China
  13.8.2 India
  13.8.3 Japan
  13.8.4 Singapore
  13.8.5 Australia
  13.8.6 New Zealand
  13.8.7 Rest of APAC

Chapter 14: Middle East & Africa Animal Parasiticides Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Ectoparasiticides
  14.4.2 Endoparasiticides
  14.4.3 Endectocides
 14.5 Historic and Forecasted Market Size By Animal Type
  14.5.1 Companion Animals
  14.5.2 Livestock Animals
 14.6 Historic and Forecasted Market Size By End User
  14.6.1 Animal Farms
  14.6.2 Home Care Settings
  14.6.3 Veterinary Clinics & Hospitals
 14.7 Historic and Forecasted Market Size By Distribution Channels
  14.7.1 Veterinary Hospitals & Clinics
  14.7.2 Pharmacies
  14.7.3 Drug Stores
 14.8 Historic and Forecast Market Size by Country
  14.8.1 Turkey
  14.8.2 Saudi Arabia
  14.8.3 Iran
  14.8.4 UAE
  14.8.5 Africa
  14.8.6 Rest of MEA

Chapter 15: South America Animal Parasiticides Market Analysis, Insights and Forecast, 2016-2028
 15.1 Key Market Trends, Growth Factors and Opportunities
 15.2 Impact of Covid-19
 15.3 Key Players
 15.4 Key Market Trends, Growth Factors and Opportunities
 15.4 Historic and Forecasted Market Size By Type
  15.4.1 Ectoparasiticides
  15.4.2 Endoparasiticides
  15.4.3 Endectocides
 15.5 Historic and Forecasted Market Size By Animal Type
  15.5.1 Companion Animals
  15.5.2 Livestock Animals
 15.6 Historic and Forecasted Market Size By End User
  15.6.1 Animal Farms
  15.6.2 Home Care Settings
  15.6.3 Veterinary Clinics & Hospitals
 15.7 Historic and Forecasted Market Size By Distribution Channels
  15.7.1 Veterinary Hospitals & Clinics
  15.7.2 Pharmacies
  15.7.3 Drug Stores
 15.8 Historic and Forecast Market Size by Country
  15.8.1 Brazil
  15.8.2 Argentina
  15.8.3 Rest of SA

Chapter 16 Investment Analysis

Chapter 17 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. ANIMAL PARASITICIDES MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. ANIMAL PARASITICIDES MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. ANIMAL PARASITICIDES MARKET COMPETITIVE RIVALRY
TABLE 005. ANIMAL PARASITICIDES MARKET THREAT OF NEW ENTRANTS
TABLE 006. ANIMAL PARASITICIDES MARKET THREAT OF SUBSTITUTES
TABLE 007. ANIMAL PARASITICIDES MARKET BY TYPE
TABLE 008. ECTOPARASITICIDES MARKET OVERVIEW (2016-2028)
TABLE 009. ENDOPARASITICIDES MARKET OVERVIEW (2016-2028)
TABLE 010. ENDECTOCIDES MARKET OVERVIEW (2016-2028)
TABLE 011. ANIMAL PARASITICIDES MARKET BY ANIMAL TYPE
TABLE 012. COMPANION ANIMALS MARKET OVERVIEW (2016-2028)
TABLE 013. LIVESTOCK ANIMALS MARKET OVERVIEW (2016-2028)
TABLE 014. ANIMAL PARASITICIDES MARKET BY END USER
TABLE 015. ANIMAL FARMS MARKET OVERVIEW (2016-2028)
TABLE 016. HOME CARE SETTINGS MARKET OVERVIEW (2016-2028)
TABLE 017. VETERINARY CLINICS & HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 018. ANIMAL PARASITICIDES MARKET BY DISTRIBUTION CHANNELS
TABLE 019. VETERINARY HOSPITALS & CLINICS MARKET OVERVIEW (2016-2028)
TABLE 020. PHARMACIES MARKET OVERVIEW (2016-2028)
TABLE 021. DRUG STORES MARKET OVERVIEW (2016-2028)
TABLE 022. NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY TYPE (2016-2028)
TABLE 023. NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE (2016-2028)
TABLE 024. NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY END USER (2016-2028)
TABLE 025. NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNELS (2016-2028)
TABLE 026. N ANIMAL PARASITICIDES MARKET, BY COUNTRY (2016-2028)
TABLE 027. EUROPE ANIMAL PARASITICIDES MARKET, BY TYPE (2016-2028)
TABLE 028. EUROPE ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE (2016-2028)
TABLE 029. EUROPE ANIMAL PARASITICIDES MARKET, BY END USER (2016-2028)
TABLE 030. EUROPE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNELS (2016-2028)
TABLE 031. ANIMAL PARASITICIDES MARKET, BY COUNTRY (2016-2028)
TABLE 032. ASIA PACIFIC ANIMAL PARASITICIDES MARKET, BY TYPE (2016-2028)
TABLE 033. ASIA PACIFIC ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE (2016-2028)
TABLE 034. ASIA PACIFIC ANIMAL PARASITICIDES MARKET, BY END USER (2016-2028)
TABLE 035. ASIA PACIFIC ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNELS (2016-2028)
TABLE 036. ANIMAL PARASITICIDES MARKET, BY COUNTRY (2016-2028)
TABLE 037. MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY TYPE (2016-2028)
TABLE 038. MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE (2016-2028)
TABLE 039. MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY END USER (2016-2028)
TABLE 040. MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNELS (2016-2028)
TABLE 041. ANIMAL PARASITICIDES MARKET, BY COUNTRY (2016-2028)
TABLE 042. SOUTH AMERICA ANIMAL PARASITICIDES MARKET, BY TYPE (2016-2028)
TABLE 043. SOUTH AMERICA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE (2016-2028)
TABLE 044. SOUTH AMERICA ANIMAL PARASITICIDES MARKET, BY END USER (2016-2028)
TABLE 045. SOUTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNELS (2016-2028)
TABLE 046. ANIMAL PARASITICIDES MARKET, BY COUNTRY (2016-2028)
TABLE 047. BAYER AG: SNAPSHOT
TABLE 048. BAYER AG: BUSINESS PERFORMANCE
TABLE 049. BAYER AG: PRODUCT PORTFOLIO
TABLE 050. BAYER AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. ZOETIS INC.: SNAPSHOT
TABLE 051. ZOETIS INC.: BUSINESS PERFORMANCE
TABLE 052. ZOETIS INC.: PRODUCT PORTFOLIO
TABLE 053. ZOETIS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. VIRBAC SA: SNAPSHOT
TABLE 054. VIRBAC SA: BUSINESS PERFORMANCE
TABLE 055. VIRBAC SA: PRODUCT PORTFOLIO
TABLE 056. VIRBAC SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. ELANCO ANIMAL HEALTH: SNAPSHOT
TABLE 057. ELANCO ANIMAL HEALTH: BUSINESS PERFORMANCE
TABLE 058. ELANCO ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 059. ELANCO ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. ELANCO ANIMAL HEALTH INCORPORATED: SNAPSHOT
TABLE 060. ELANCO ANIMAL HEALTH INCORPORATED: BUSINESS PERFORMANCE
TABLE 061. ELANCO ANIMAL HEALTH INCORPORATED: PRODUCT PORTFOLIO
TABLE 062. ELANCO ANIMAL HEALTH INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. VIRBAC: SNAPSHOT
TABLE 063. VIRBAC: BUSINESS PERFORMANCE
TABLE 064. VIRBAC: PRODUCT PORTFOLIO
TABLE 065. VIRBAC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. MERCK & CO. INC.: SNAPSHOT
TABLE 066. MERCK & CO. INC.: BUSINESS PERFORMANCE
TABLE 067. MERCK & CO. INC.: PRODUCT PORTFOLIO
TABLE 068. MERCK & CO. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. BOEHRINGER INGELHEIM GMBH: SNAPSHOT
TABLE 069. BOEHRINGER INGELHEIM GMBH: BUSINESS PERFORMANCE
TABLE 070. BOEHRINGER INGELHEIM GMBH: PRODUCT PORTFOLIO
TABLE 071. BOEHRINGER INGELHEIM GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 071. BIMEDA ANIMAL HEALTH: SNAPSHOT
TABLE 072. BIMEDA ANIMAL HEALTH: BUSINESS PERFORMANCE
TABLE 073. BIMEDA ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 074. BIMEDA ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 074. MERCK ANIMAL HEALTH: SNAPSHOT
TABLE 075. MERCK ANIMAL HEALTH: BUSINESS PERFORMANCE
TABLE 076. MERCK ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 077. MERCK ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 077. CEVA SANTÉ ANIMALE: SNAPSHOT
TABLE 078. CEVA SANTÉ ANIMALE: BUSINESS PERFORMANCE
TABLE 079. CEVA SANTÉ ANIMALE: PRODUCT PORTFOLIO
TABLE 080. CEVA SANTÉ ANIMALE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 080. VETOQUINOL S.A.: SNAPSHOT
TABLE 081. VETOQUINOL S.A.: BUSINESS PERFORMANCE
TABLE 082. VETOQUINOL S.A.: PRODUCT PORTFOLIO
TABLE 083. VETOQUINOL S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 083. PETIQ INC.: SNAPSHOT
TABLE 084. PETIQ INC.: BUSINESS PERFORMANCE
TABLE 085. PETIQ INC.: PRODUCT PORTFOLIO
TABLE 086. PETIQ INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 086. NORBROOK: SNAPSHOT
TABLE 087. NORBROOK: BUSINESS PERFORMANCE
TABLE 088. NORBROOK: PRODUCT PORTFOLIO
TABLE 089. NORBROOK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 089. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 090. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 091. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 092. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. ANIMAL PARASITICIDES MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. ANIMAL PARASITICIDES MARKET OVERVIEW BY TYPE
FIGURE 012. ECTOPARASITICIDES MARKET OVERVIEW (2016-2028)
FIGURE 013. ENDOPARASITICIDES MARKET OVERVIEW (2016-2028)
FIGURE 014. ENDECTOCIDES MARKET OVERVIEW (2016-2028)
FIGURE 015. ANIMAL PARASITICIDES MARKET OVERVIEW BY ANIMAL TYPE
FIGURE 016. COMPANION ANIMALS MARKET OVERVIEW (2016-2028)
FIGURE 017. LIVESTOCK ANIMALS MARKET OVERVIEW (2016-2028)
FIGURE 018. ANIMAL PARASITICIDES MARKET OVERVIEW BY END USER
FIGURE 019. ANIMAL FARMS MARKET OVERVIEW (2016-2028)
FIGURE 020. HOME CARE SETTINGS MARKET OVERVIEW (2016-2028)
FIGURE 021. VETERINARY CLINICS & HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 022. ANIMAL PARASITICIDES MARKET OVERVIEW BY DISTRIBUTION CHANNELS
FIGURE 023. VETERINARY HOSPITALS & CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 024. PHARMACIES MARKET OVERVIEW (2016-2028)
FIGURE 025. DRUG STORES MARKET OVERVIEW (2016-2028)
FIGURE 026. NORTH AMERICA ANIMAL PARASITICIDES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. EUROPE ANIMAL PARASITICIDES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. ASIA PACIFIC ANIMAL PARASITICIDES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. SOUTH AMERICA ANIMAL PARASITICIDES MARKET OVERVIEW BY COUNTRY (2016-2028)